Fenwick & West represented BioAge Labs in the transaction. BioAge Labs (BioAge) announced it completed the oversubscribed $170M Series D financing round led by Sofinnova Investments...
BioAge’s $170 Million Series D Financing Round
JN BIDCO’s Acquisition of Impel Pharmaceuticals
Fenwick & West and Sidley Austin are representing Impel Pharmaceuticals Inc. in the transaction. JN BIDCO LLC announced the acquisition of Impel Pharmaceuticals Inc. (OTCQX: IMPL)....
Scribe Therapeutics’ Collaboration with Sanofi
Fenwick represented Scribe Therapeutics on the deal. Scribe Therapeutics, a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, announced its strategic collaboration and...
Impel NeuroPharma’s $80 Million Initial Public Offering
Fenwick & West LLP advised Impel NeuroPharma on the deal. Impel NeuroPharma, a late-stage pharmaceutical company developing transformative therapies for diseases of the central nervous system, announced its...